{
    "clinical_study": {
        "@rank": "164775", 
        "acronym": "CAVI-J", 
        "arm_group": {
            "arm_group_label": "Optimal therapy", 
            "description": "All subjects will be treated by optimal medical therapy and lifestyle modification."
        }, 
        "brief_summary": {
            "textblock": "The objective of this five-year prospective observational follow-up study is to examine the\n      additional benefits of using cardio-ankle vascular index (CAVI) as a predictive indicator of\n      cardiovascular events in high-risk patients."
        }, 
        "brief_title": "A Prospective Multicenter Study to Evaluate Usefulness of Cardio-Ankle Vascular Index in Japan", 
        "condition": [
            "Stroke", 
            "Cardiovascular Death", 
            "Nonfatal Myocardial Infarction"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Infarction", 
                "Myocardial Infarction", 
                "Stroke"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Patients between 40 and 74 years of age who have either of the following:\n\n          1. Type 2 diabetes mellitus\n\n          2. Metabolic syndrome\n\n          3. Grade I to III hypertension with the third layer of risk factors according to the\n             guidelines for the management of hypertension japanese society of\n             hypertension(JSH)2009\n\n          4. Chronic kidney disease(stage G3a or G3b) according ot the clinical Practice Guidebook\n             for Diagnosis and Treatment of Chronic Kidney Disease 2012 in Japan\n\n          5. History of coronary artery disease or noncardiogenic cerebral infarction\n\n        Exclusion Criteria:\n\n          1. Under 40 years of age or over 74 years of age\n\n          2. An ankle-brachial index less than 0.9\n\n          3. Chronic atrial fibrillation\n\n          4. Current symptoms of heart failure(NYHA class III or IV) or left ventricular\n             dysfunction (EF below 40%)\n\n          5. Malignancy\n\n          6. Chronic kidney disease(G4 or G5)according ot the clinical Practice Guidebook for\n             Diagnosis and Treatment of Chronic Kidney Disease 2012 in Japan\n\n          7. chronic dialysis due to renal failure\n\n          8. Taking steroids/immunosuppressants\n\n          9. Hepatocirrhosis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "74 Years", 
            "minimum_age": "40 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "primiary care clinic and hospital"
            }
        }, 
        "enrollment": {
            "#text": "3000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01859897", 
            "org_study_id": "okayama-1692"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 5, 2013", 
        "link": {
            "description": "Click here for more information about this study (in Japanese)", 
            "url": "http://www.cavij.com/"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Okayama", 
                    "country": "Japan", 
                    "zip": "700-8558"
                }, 
                "name": "Okayama University"
            }, 
            "investigator": {
                "last_name": "Hiroshi Ito, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Prospective Multicenter Study to Evaluate Usefulness of Cardio-Ankle Vascular Index in Japan", 
        "other_outcome": {
            "description": "Angina pectoris (with revascularization), New incidence of lower limb peripheral arterial disease(including lower limb arteriosclerosis obliterans), Aortic aneurysm, Aortic dissection, Heart failure that requires hospitalization, Deterioration in renal function (dialysis or renal transplantation)", 
            "measure": "cardiovascular events", 
            "safety_issue": "No", 
            "time_frame": "five years"
        }, 
        "overall_contact": {
            "email": "miyoshit@cc.okayama-u.ac.jp", 
            "last_name": "Toru Miyoshi, MD", 
            "phone": "81-86-235-7351"
        }, 
        "overall_official": {
            "affiliation": "Kenkoin Clinic", 
            "last_name": "Hajime Orimo, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Japan:The ethics committee of Okayama University", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2019", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "cardiac death, nonfatal myocardial infarction, stroke", 
            "measure": "major cardiac events", 
            "safety_issue": "No", 
            "time_frame": "five years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01859897"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Okayama University", 
            "investigator_full_name": "CAVI-J Study Group", 
            "investigator_title": "CAVI-J study Group", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "measure": "all cause mortality", 
            "safety_issue": "No", 
            "time_frame": "five years"
        }, 
        "source": "Okayama University", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Toho University School of Medicine", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Ehime University Graduate School of Medicine", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Dokkyo Medical University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Okayama University", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "CAVI-J Study Group", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "5 Years", 
        "verification_date": "June 2013"
    }
}